from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3095/-

LFCtreatmentdescriptionclass of inhibitor

-0.417

Amikacinug/mL Amikacintranslation

-0.614

Cap5-10ug/mL Capreomycintranslation

-0.757

Rox10-50 ug/mL Roxithromycintranslation

-0.551

SM2-5 ug/mL Streptomycintranslation

-0.781

Tet5-10 ug/mL Tetracyclinetranslation

0.025

Rif0.2-5ug/mL Rifampicintranscription

-0.684

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.624

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.010

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.475

CPZ10-50 ug/mL Chlorpromazinerespiration

1.860

Clofazimine10-13 ug/mL Clofaziminerespiration

0.512

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.637

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.469

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.457

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.885

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.201

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.010

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.760

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.744

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.623

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.924

Nigericin50 uM Nigericinrespiration

0.048

TRC10-150 ug/mL Triclosanrespiration

1.526

TRZ10-25 ug/mL Thioridazinerespiration

-0.851

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.198

menadione6-10 ug/mL Menadionerespiration

0.967

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.321

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.058

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.167

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.553

NRP_1Non-replicating persistence stage 1dosRassociated

-0.067

Amp0.2mg/mL AmpicillincellWall

0.787

Cephalexin20-100 ug/mL CephalexincellWall

0.687

Cerulenin0.32-5 ug/mL CerulenincellWall

0.066

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.370

EMB10-20 ug/mL EthambutolcellWall

1.431

Eta12-40 ug/mL EthionamidecellWall

1.386

INH0.2-0.4 ug/mL IsoniazidcellWall

1.248

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.097

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.655

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.179

BZA0.12 mg/mL BenzamidearomaticAmides

-1.163

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.757

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.376

H2O24 mM hydrogen peroxideDNAdamaging

-1.205

Levo10 ug/mL LevofloxacinDNAdamaging

-0.974

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.059

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.157

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.331

UVUV-irradiationDNAdamaging

0.921

ARP41-4 ug/mL Antitubercular compound ARP4?

0.762

Antimycin12.5-50 ug/mL Antimycin A?

-0.941

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.219

PA_110-50 ug/mL Antitubercular compound PA-1?

0.219

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.087

PA8240.2-2 ug/mL PA-824?

1.367

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.969

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.070

Verapamil50 uM Verapamil?

-1.031

mercaptoethanol2 mM 2-Mercaptoethanol?

0.699

methoxatin10-20 ug/mL Methoxatin?